Citation Impact
Citing Papers
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
2010 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
2012 Standout
Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: A double-blind placebo-controlled trial
2008
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
2010 Standout
Randomised clinical trials of fish oil supplementation in high risk pregnancies
2000
Impact of dental care in the prevention of bisphosphonate-associated osteonecrosis of the jaw: a single-center clinical experience
2011
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2014 Standout
Breast cancer
2016 Standout
American College of Gastroenterology Guideline: Management of Acute Pancreatitis
2013 Standout
A new look at the heart in diabetes mellitus: from ailing to failing
2000
Cancer to bone: a fatal attraction
2011 Standout
The Cathepsin K Inhibitor Odanacatib Suppresses Bone Resorption in Women With Breast Cancer and Established Bone Metastases: Results of a 4-Week, Double-Blind, Randomized, Controlled Trial
2010
Beneficial effects of C‐peptide on incipient nephropathy and neuropathy in patients with Type 1 diabetes mellitus
2000
Demyelinating Neuropathy in Diabetes Mellitus
2002
Skeletal-Related Events due to Bone Metastases from Differentiated Thyroid Cancer
2012
Serum from patients with type 2 diabetes with neuropathy induces complement-independent, calcium-dependent apoptosis in cultured neuronal cells.
1998
Physiology and immunology of the cholinergic antiinflammatory pathway
2007 Standout
Macrophages in immunoregulation and therapeutics
2023 Standout
Role of Bisphosphonates in Breast Cancer Therapy
2019
Imaging transforming growth factor-β signaling dynamics and therapeutic response in breast cancer bone metastasis
2009
Cardiac autonomic neuropathy in diabetic patients: influence of diabetes duration, obesity, and microangiopathic complications—the french multicenter study
2003
Alcohol and public health
2005 Standout
Effect of bisphosphonates on pain and quality of life in patients with bone metastases
2009
A Systematic Review and Meta-Analysis of the Pharmacological Treatment of Cancer-Related Fatigue
2008
The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors
2002 Standout
Autonomic Vagal Nerve Dysfunction in Patients with Ulcerative Colitis
1993
Peripheral and autonomic nerve function in 259 diabetic patients with peripheral neuropathy treated with ponalrestat (an aldose reductase inhibitor) or placebo for 18 months
1992
F-wave latency serves as the most reproducible measure in nerve conduction studies of diabetic polyneuropathy: multicentre analysis in healthy subjects and patients with diabetic polyneuropathy
2000
Delivery technologies for cancer immunotherapy
2019 Standout
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Impact of skeletal complications on patients’ quality of life, mobility, and functional independence
2008
Comparison of the efficacy and safety of denosumab versus bisphosphonates in breast cancer and bone metastases treatment: A meta-analysis of randomized controlled trials
2014
Rituximab in the treatment of polyneuropathy associated with anti‐MAG antibodies
2003
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel
2007
Cues to deception.
2003 Standout
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
2020 Standout
Reflex control of immunity
2009 Standout
Current options for the management of postmenopausal osteoporosis
2011
Bisphosphonates in breast cancer
2005
Human pancreatic exocrine response to nutrients in health and disease
2005
Bisphosphonates for cancer treatment: Mechanisms of action and lessons from clinical trials
2015
Static magnetic field therapy for symptomatic diabetic neuropathy: a randomized, double-blind, placebo-controlled trial
2003
Bone health in cancer patients: ESMO Clinical Practice Guidelines
2014
Biochemical Markers of Bone Turnover in the Clinical Development of Drugs for Osteoporosis and Metastatic Bone Disease
2006
Wisconsin Ginseng (Panax quinquefolius) to Improve Cancer-Related Fatigue: A Randomized, Double-Blind Trial, N07C2
2013
Evolving cancer–niche interactions and therapeutic targets during bone metastasis
2021
Chronic arthritis leads to disturbances in the bone collagen network
2010 StandoutNobel
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Long-Term Complications of Diabetes Mellitus
1993 Standout
Cancer treatment and survivorship statistics, 2012
2012 Standout
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Diabetes impairs the enzymatic disposal of 4-hydroxynonenal in rat liver
2002
NCCN Task Force Report: Bone Health in Cancer Care
2009
Tumour-associated macrophages as treatment targets in oncology
2017 Standout
Paradoxical roles of the immune system during cancer development
2006 Standout
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Tumor metastasis: mechanistic insights and clinical challenges
2006 Standout
Cancer-related fatigue—mechanisms, risk factors, and treatments
2014 Standout
Genomic instability — an evolving hallmark of cancer
2010 Standout
Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan
2008
Electrophysiologic measures of diabetic neuropathy: Mechanism and meaning
2002
Preventing Foot Ulcers in Patients With Diabetes
2005 Standout
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
2015
Techniques to Enhance Compliance with Disulfiram
1992
Photoplethysmography and its application in clinical physiological measurement
2007 Standout
Adverse Effects of Androgen Deprivation Therapy and Strategies to Mitigate Them
2014 Standout
How the ear's works work
1989 StandoutNature
Right-left correlation of the sympathetically induced fluctuations of photoplethysmographic signal in diabetic and non-diabetic subjects
2005
Effect of Metabolic Control on Autonomic Function in Obese Patients with Newly Diagnosed Type 2 Diabetes
1993
The cancer genome
2009 StandoutNature
Clinical trials for drugs against diabetic neuropathy: Can we combine scientific needs with clinical practicalities?
2002
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
Carpal Tunnel Syndrome in Patients With Diabetic Polyneuropathy
2002
Diabetic Neuropathies
2005 Standout
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
2015 Standout
Bisphosphonates: Clinical Experience
2004
Periodontal disease and bisphosphonates induce osteonecrosis of the jaws in the rat
2011
Reconceptualizing arousal: Psychobiological states in motor performance.
1988
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
2014 Standout
Optimizing Clinical Benefits of Bisphosphonates in Cancer Patients with Bone Metastases
2010
Zoledronic Acid Significantly Reduces Skeletal Complications Compared With Placebo in Japanese Women With Bone Metastases From Breast Cancer: A Randomized, Placebo-Controlled Trial
2005
The fine structure of freeze-fractured intercellular junctions in the guinea pig inner ear
1975
Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments
2010 Standout
Bisphosphonates in oncology: evidence for the prevention of skeletal events in patients with bone metastases
2008
Heterocyclic Anticancer Compounds: Recent Advances and the Paradigm Shift towards the Use of Nanomedicine’s Tool Box
2015 Standout
Fruit and vegetable intake and the risk of cardiovascular disease, total cancer and all-cause mortality—a systematic review and dose-response meta-analysis of prospective studies
2016 Standout
PEGylation in anti-cancer therapy: An overview
2015
NCCN Task Force Report: Bone Health in Cancer Care
2013
Mechanisms of Diabetic Complications
2013 Standout
PHARMACOTHERAPY OF ALCOHOLISM: GAPS IN KNOWLEDGE AND OPPORTUNITIES FOR RESEARCH
2000
A Randomized, Double-Blinded, Placebo-Controlled Phase II Trial of Recombinant Human Leukemia Inhibitory Factor (rhuLIF, Emfilermin, AM424) to Prevent Chemotherapy-Induced Peripheral Neuropathy
2005
Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity
2006 Standout
Diabetic Somatic Neuropathies
2004 Standout
Diabetic Neuropathy: A Position Statement by the American Diabetes Association
2016 Standout
Diabetic Autonomic Neuropathy
2003 Standout
DNA Repair Pathways in Clinical Practice: Lessons From Pediatric Cancer Susceptibility Syndromes
2006
Guidelines for the management of thyroid cancer
2014 Standout
A study of the biological receptor activator of nuclear factor-kappaB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer.
2006
Simple Screening Tests for Peripheral Neuropathy in the Diabetes Clinic
2001
American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update
2014 Standout
Works of B. Bergström being referenced
Chlorpropamide-alcohol flushing, aldehyde dehydrogenase activity, and diabetic complications.
1982
TRACKING PERFORMANCE UNDER THREAT‐INDUCED STRESS
1970
Improved quality of life after long-term treatment with the bisphosphonate ibandronate in patients with metastatic bone disease due to breast cancer
2004
Autonomic neuropathy in non‐insulin dependent (type II) diabetes mellitus. Possible influence of obesity
1990
Prospective Study of Autonomic Nerve Function in Type 1 and Type 2 Diabetic Patients: 24 Hour Heart Rate Variation and Plasma Motilin Levels Disturbed in Parasympathetic Neuropathy
1995
Oral ibandronate for the treatment of metastatic bone disease in breast cancer: efficacy and safety results from a randomized, double-blind, placebo-controlled trial
2004
Oral ibandronate is as active as intravenous zoledronic acid for reducing bone turnover markers in women with breast cancer and bone metastases
2007
Impaired responses of plasma catecholamines to exercise in diabetic patients with abnormal heart rate reactions to tilt
1989
Platelet sodium and potassium ATP activity and noradrenaline efflux rate in relation to autonomic and peripheral nerve function in insulin‐dependent diabetic patients
1989
Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases
2003
Electrophysiological monitoring in clinical trials
1998
Oral ibandronate improves bone pain and preserves quality of life in patients with skeletal metastases due to breast cancer
2004
Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies
2004
Autonomic Neuropathy in Type I Diabetes: Influence of Duration and Other Diabetic Complications
1987
Phase II, randomized, multicenter, comparative study of peginterferon–α–2a (40 kD) (Pegasys®)versusinterferon α-2a (Roferon®-A) in patients with treatment-naïve, chronic-phase chronic myelogenous leukemia
2007
Renal safety profiles of ibandronate 6 mg infused over 15 and 60 min: a randomized, open-label study
2008
Electrophysiological monitoring in clinical trials
1998
IS DISULFIRAM IMPLANTATION EFFECTIVE?
1982
Effect of 1-year intravenous ibandronate treatment on time to serum creatinine increase in patients with skeletal metastases from breast cancer
2004
Effect of oral ibandronate versus intravenous (i.v.) zoledronic acid on markers of bone resorption in patients with breast cancer and bone metastases: Results from a comparative phase III trial
2005
Vestibular Sensory Epithelia
1974
Sensory nerve area measurements in patients with diabetic neuropathy.
2001
Renal safety of intravenous ibandronate 6mg infused over 15 or 60 minutes in patients with breast cancer and bone metastases: A randomized, open-label study
2007
Autonomic nerve antibodies and autonomic nerve function in Type 1 and Type 2 diabetic patients
1991
Safety of an intravenous (i.v.) dose of ibandronate followed by daily oral dosing in metastatic bone disease: Results of an open-label study
2004
Autonomic nerve function tests. Reference values in healthy subjects
1986